SCHEMBL23359133

SCHEMBL23359133

COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(c(CN(C)C)c(O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB11 O95342 5/20 0.76
▸ TBXA2R P21731 3/20 0.76
▸ CHRM1 P11229 3/20 0.76
▸ PTGS1 P23219 3/20 0.76
▸ SLCO2B1 O94956 2/20 0.76
▸ ADRA1A P35348 2/20 0.76
▸ SLCO1A2 P46721 2/20 0.76
▸ SLCO1B3 Q9NPD5 2/20 0.76
▸ SLCO1B1 Q9Y6L6 2/20 0.76
▸ MAPT P10636 4/20 0.72
▸ ABCC4 O15439 4/20 0.72
▸ ABCC2 Q92887 4/20 0.72
▸ GAA P10253 3/20 0.72
▸ MAPK1 P28482 3/20 0.72
▸ ABCC3 O15438 3/20 0.72
▸ ALDH1A1 P00352 2/20 0.72
▸ NR1I2 O75469 2/20 0.72
▸ ADRB2 P07550 2/20 0.72
▸ ADRB1 P08588 2/20 0.72
▸ ADORA3 P0DMS8 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31715689 1.00 ABCB11 (0.76) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL31715785 1.00 ABCB11 (0.76) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL29702867 0.94 ABCB11 (0.74) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL29793694 0.94 ABCB11 (0.74) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL13478018 0.94 ABCB11 (0.74) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL13478015 0.92 ABCB11 (0.76) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL31447566 0.91 ABCB11 (0.83) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL13478012 0.91 ABCB11 (0.73) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL13478033 0.90 ABCB11 (0.73) ABCB11TBXA2RCHRM1PTGS1SLCO2B1
SCHEMBL29642384 0.90 ABCB11 (0.73) ABCB11TBXA2RCHRM1PTGS1SLCO2B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210144998-A1 COMPOSITIONS AND METHODS FOR TREATING HUANGLONGBING DISEASE IN CITRUS NEW LIFE CROP SCIENCES LLC 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210144998-A1 COMPOSITIONS AND METHODS FOR TREATING HUANGLONGBING DISEASE IN CITRUS PNPO, G6PD, AGXT ABCB11 1266/4885TBXA2R 3930/4885CHRM1 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback